EQIX vs SMMT · P/E 79, rev $5.07B vs $11.46B cap
Equinix Inc (EQIX) versus Summit Therapeutics PLC (SMMT) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Summit Therapeutics PLC (SMMT) is a biotechnology company listed on US.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
SMMT does not have a complete income-statement cache yet.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. SMMT currently screens at market cap $11.46B.
Not investment advice. Open the EQIX and SMMT stock pages for the full models.
Not investment advice.